Cargando…

Mutual Inhibition between Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Lytic Replication Initiators in Dually-Infected Primary Effusion Lymphoma

BACKGROUND: Both Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) are members of the human gamma herpesvirus family: each is associated with various human cancers. The majority of AIDS-associated primary effusion lymphoma (PEL) are co-infected with both KSHV and EBV....

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yanjun, Xu, Dongsheng, Zhao, Yong, Zhang, Luwen
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2215330/
https://www.ncbi.nlm.nih.gov/pubmed/18253508
http://dx.doi.org/10.1371/journal.pone.0001569
_version_ 1782149012595408896
author Jiang, Yanjun
Xu, Dongsheng
Zhao, Yong
Zhang, Luwen
author_facet Jiang, Yanjun
Xu, Dongsheng
Zhao, Yong
Zhang, Luwen
author_sort Jiang, Yanjun
collection PubMed
description BACKGROUND: Both Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) are members of the human gamma herpesvirus family: each is associated with various human cancers. The majority of AIDS-associated primary effusion lymphoma (PEL) are co-infected with both KSHV and EBV. Dually-infected PELs selectively switch from latency to lytic replication of either KSHV or EBV in response to chemical stimuli. KSHV replication and transcription activator (K-RTA) is necessary and sufficient for the switch from KSHV latency to lytic replication, while EBV BZLF1 gene product (EBV-Z) is a critical initiator for induction of EBV lytic replication. METHODOLOGY/PRINCIPAL FINDINGS: We show K-RTA and EBV-Z are co-localized and physically interact with each other in dually-infected PELs. K-RTA inhibits the EBV lytic replication by nullifying EBV-Z-mediated EBV lytic gene activation. EBV-Z inhibits KSHV lytic gene expression by blocking K-RTA-mediated transactivations. The physical interaction between K-RTA and EBV-Z are required for the mutual inhibition of the two molecules. The leucine heptapeptide repeat (LR) region in K-RTA and leucine zipper region in EBV-Z are involved in the physical interactions of the two molecules. Finally, initiation of KSHV lytic gene expression is correlated with the reduction of EBV lytic gene expression in the same PEL cells. CONCLUSIONS/SIGNIFICANCE: In this report, how the two viruses interact with each other in dually infected PELs is addressed. Our data may provide a possible mechanism for maintaining viral latency and for selective lytic replication in dually infected PELs, i.e., through mutual inhibition of two critical lytic replication initiators. Our data about putative interactions between EBV and KSHV would be applicable to the majority of AIDS-associated PELs and may be relevant to the pathogenesis of PELs.
format Text
id pubmed-2215330
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-22153302008-02-06 Mutual Inhibition between Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Lytic Replication Initiators in Dually-Infected Primary Effusion Lymphoma Jiang, Yanjun Xu, Dongsheng Zhao, Yong Zhang, Luwen PLoS One Research Article BACKGROUND: Both Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) are members of the human gamma herpesvirus family: each is associated with various human cancers. The majority of AIDS-associated primary effusion lymphoma (PEL) are co-infected with both KSHV and EBV. Dually-infected PELs selectively switch from latency to lytic replication of either KSHV or EBV in response to chemical stimuli. KSHV replication and transcription activator (K-RTA) is necessary and sufficient for the switch from KSHV latency to lytic replication, while EBV BZLF1 gene product (EBV-Z) is a critical initiator for induction of EBV lytic replication. METHODOLOGY/PRINCIPAL FINDINGS: We show K-RTA and EBV-Z are co-localized and physically interact with each other in dually-infected PELs. K-RTA inhibits the EBV lytic replication by nullifying EBV-Z-mediated EBV lytic gene activation. EBV-Z inhibits KSHV lytic gene expression by blocking K-RTA-mediated transactivations. The physical interaction between K-RTA and EBV-Z are required for the mutual inhibition of the two molecules. The leucine heptapeptide repeat (LR) region in K-RTA and leucine zipper region in EBV-Z are involved in the physical interactions of the two molecules. Finally, initiation of KSHV lytic gene expression is correlated with the reduction of EBV lytic gene expression in the same PEL cells. CONCLUSIONS/SIGNIFICANCE: In this report, how the two viruses interact with each other in dually infected PELs is addressed. Our data may provide a possible mechanism for maintaining viral latency and for selective lytic replication in dually infected PELs, i.e., through mutual inhibition of two critical lytic replication initiators. Our data about putative interactions between EBV and KSHV would be applicable to the majority of AIDS-associated PELs and may be relevant to the pathogenesis of PELs. Public Library of Science 2008-02-06 /pmc/articles/PMC2215330/ /pubmed/18253508 http://dx.doi.org/10.1371/journal.pone.0001569 Text en Jiang et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Jiang, Yanjun
Xu, Dongsheng
Zhao, Yong
Zhang, Luwen
Mutual Inhibition between Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Lytic Replication Initiators in Dually-Infected Primary Effusion Lymphoma
title Mutual Inhibition between Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Lytic Replication Initiators in Dually-Infected Primary Effusion Lymphoma
title_full Mutual Inhibition between Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Lytic Replication Initiators in Dually-Infected Primary Effusion Lymphoma
title_fullStr Mutual Inhibition between Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Lytic Replication Initiators in Dually-Infected Primary Effusion Lymphoma
title_full_unstemmed Mutual Inhibition between Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Lytic Replication Initiators in Dually-Infected Primary Effusion Lymphoma
title_short Mutual Inhibition between Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Lytic Replication Initiators in Dually-Infected Primary Effusion Lymphoma
title_sort mutual inhibition between kaposi's sarcoma-associated herpesvirus and epstein-barr virus lytic replication initiators in dually-infected primary effusion lymphoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2215330/
https://www.ncbi.nlm.nih.gov/pubmed/18253508
http://dx.doi.org/10.1371/journal.pone.0001569
work_keys_str_mv AT jiangyanjun mutualinhibitionbetweenkaposissarcomaassociatedherpesvirusandepsteinbarrviruslyticreplicationinitiatorsinduallyinfectedprimaryeffusionlymphoma
AT xudongsheng mutualinhibitionbetweenkaposissarcomaassociatedherpesvirusandepsteinbarrviruslyticreplicationinitiatorsinduallyinfectedprimaryeffusionlymphoma
AT zhaoyong mutualinhibitionbetweenkaposissarcomaassociatedherpesvirusandepsteinbarrviruslyticreplicationinitiatorsinduallyinfectedprimaryeffusionlymphoma
AT zhangluwen mutualinhibitionbetweenkaposissarcomaassociatedherpesvirusandepsteinbarrviruslyticreplicationinitiatorsinduallyinfectedprimaryeffusionlymphoma